KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $3.0 million.

  • Pacific Biosciences Of California's Non Operating Income fell 5647.31% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year decrease of 4287.04%. This contributed to the annual value of $23.8 million for FY2024, which is 2723.35% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its Non Operating Income stood at $3.0 million for Q3 2025, which was down 5647.31% from $4.7 million recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Non Operating Income high stood at $8.9 million for Q2 2023, and its period low was -$279000.0 during Q1 2022.
  • Moreover, its 5-year median value for Non Operating Income was $4.3 million (2025), whereas its average is $4.0 million.
  • Data for Pacific Biosciences Of California's Non Operating Income shows a peak YoY increase of 63470000.0% (in 2022) and a maximum YoY decrease of 53593.75% (in 2022) over the last 5 years.
  • Over the past 5 years, Pacific Biosciences Of California's Non Operating Income (Quarter) stood at $1000.0 in 2021, then surged by 634700.0% to $6.3 million in 2022, then skyrocketed by 32.06% to $8.4 million in 2023, then crashed by 51.51% to $4.1 million in 2024, then dropped by 26.22% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $4.7 million for Q2 2025, and $4.3 million during Q1 2025.